118 related articles for article (PubMed ID: 22517555)
1. Presymptomatic genetic testing in minors at risk of paraganglioma and pheochromocytoma: our experience of oncogenetic multidisciplinary consultation.
Lahlou-Laforêt K; Consoli SM; Jeunemaitre X; Gimenez-Roqueplo AP
Horm Metab Res; 2012 May; 44(5):354-8. PubMed ID: 22517555
[TBL] [Abstract][Full Text] [Related]
2. Trends of genetic screening in patients with pheochromocytoma and paraganglioma: 15-year experience in a high-volume tertiary referral center.
Asban A; Kluijfhout WP; Drake FT; Beninato T; Wang E; Chomsky-Higgins K; Shen WT; Gosnell JE; Suh I; Duh QY
J Surg Oncol; 2018 May; 117(6):1217-1222. PubMed ID: 29315604
[TBL] [Abstract][Full Text] [Related]
3. A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma.
Buffet A; Venisse A; Nau V; Roncellin I; Boccio V; Le Pottier N; Boussion M; Travers C; Simian C; Burnichon N; Abermil N; Favier J; Jeunemaitre X; Gimenez-Roqueplo AP
Horm Metab Res; 2012 May; 44(5):359-66. PubMed ID: 22517557
[TBL] [Abstract][Full Text] [Related]
4. Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center.
Pham TH; Moir C; Thompson GB; Zarroug AE; Hamner CE; Farley D; van Heerden J; Lteif AN; Young WF
Pediatrics; 2006 Sep; 118(3):1109-17. PubMed ID: 16951005
[TBL] [Abstract][Full Text] [Related]
5. Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes.
Benn DE; Richardson AL; Marsh DJ; Robinson BG
Ann N Y Acad Sci; 2006 Aug; 1073():104-11. PubMed ID: 17102077
[TBL] [Abstract][Full Text] [Related]
6. Genetics of pheochromocytoma and paraganglioma: new developments.
Pigny P; Cardot-Bauters C
Ann Endocrinol (Paris); 2010 Mar; 71(2):76-82. PubMed ID: 20031114
[TBL] [Abstract][Full Text] [Related]
7. Parent opinions regarding the genetic testing of minors for BRCA1/2.
Bradbury AR; Patrick-Miller L; Egleston B; Sands CB; Li T; Schmidheiser H; Feigon M; Ibe CN; Hlubocky FJ; Hope K; Jackson S; Corbman M; Olopade OI; Daly M; Daugherty CK
J Clin Oncol; 2010 Jul; 28(21):3498-505. PubMed ID: 20567018
[TBL] [Abstract][Full Text] [Related]
8. Probability of positive genetic testing in patients diagnosed with pheochromocytoma and paraganglioma: Criteria beyond a family history.
Alobuia WM; Ammar S; Tyagi M; Ghosh C; Gunda V; Annes JP; Kebebew E
Surgery; 2021 Feb; 169(2):298-301. PubMed ID: 33023754
[TBL] [Abstract][Full Text] [Related]
9. [Genetic diagnosis of phaeochromocytomas and paragangliomas].
Cardot-Bauters C; Ainaouï M; Coppin L; Pigny P
Presse Med; 2014 Apr; 43(4 Pt 1):460-7. PubMed ID: 24612707
[TBL] [Abstract][Full Text] [Related]
10. [Pheochromocytoma and paraganglioma].
Gimenez-Roqueplo AP
Rev Prat; 2015 Jun; 65(6):826-30. PubMed ID: 26298909
[TBL] [Abstract][Full Text] [Related]
11. Hereditary pheochromocytoma and paraganglioma.
Mazzaglia PJ
J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.
Gill AJ; Benn DE; Chou A; Clarkson A; Muljono A; Meyer-Rochow GY; Richardson AL; Sidhu SB; Robinson BG; Clifton-Bligh RJ
Hum Pathol; 2010 Jun; 41(6):805-14. PubMed ID: 20236688
[TBL] [Abstract][Full Text] [Related]
13. Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients.
Erlic Z; Rybicki L; Peczkowska M; Golcher H; Kann PH; Brauckhoff M; Müssig K; Muresan M; Schäffler A; Reisch N; Schott M; Fassnacht M; Opocher G; Klose S; Fottner C; Forrer F; Plöckinger U; Petersenn S; Zabolotny D; Kollukch O; Yaremchuk S; Januszewicz A; Walz MK; Eng C; Neumann HP;
Clin Cancer Res; 2009 Oct; 15(20):6378-85. PubMed ID: 19825962
[TBL] [Abstract][Full Text] [Related]
14. New advances in the genetics of pheochromocytoma and paraganglioma syndromes.
Gimenez-Roqueplo AP
Ann N Y Acad Sci; 2006 Aug; 1073():112-21. PubMed ID: 17102078
[TBL] [Abstract][Full Text] [Related]
15. ASO Author Reflections: Informing Patients About New Genetic Testing.
Romero Arenas MA; Grubbs EG
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):559-560. PubMed ID: 30617867
[No Abstract] [Full Text] [Related]
16. Pheochromocytoma and paraganglioma genetic testing: Psychological impact.
Martins RG; Carvalho IP
Health Psychol; 2020 Oct; 39(10):934-943. PubMed ID: 32628029
[TBL] [Abstract][Full Text] [Related]
17. Psychometric Properties of the MICRA Questionnaire in Portuguese Individuals Carrying SDHx Mutations.
Martins RG; Carvalho IP
J Cancer Educ; 2020 Oct; 35(5):1026-1033. PubMed ID: 31227996
[TBL] [Abstract][Full Text] [Related]
18. Childhood phaeochromocytoma and paraganglioma: 100% incidence of genetic mutations and 100% survival.
Hammond PJ; Murphy D; Carachi R; Davidson DF; McIntosh D
J Pediatr Surg; 2010 Feb; 45(2):383-6. PubMed ID: 20152357
[TBL] [Abstract][Full Text] [Related]
19. Late diagnosis of an index case of SDH-related paraganglioma/pheochromocytoma syndrome.
Sánchez-Pacheco Tardón M; Serrano Corredor S; Carrión A; Mauri M; Yuste A
Endocrinol Nutr; 2012 Feb; 59(2):148-50. PubMed ID: 22138625
[No Abstract] [Full Text] [Related]
20. Genetic Screening in Pheochromocytoma/Paraganglioma.
Liu P; Zu X; Liu L
Pathol Oncol Res; 2017 Jan; 23(1):217. PubMed ID: 27699629
[No Abstract] [Full Text] [Related]
[Next] [New Search]
